Aug 03, 2022 / 01:00PM GMT
Anna Niedl - Medigene AG - VP IR & Corporate Communications
Good afternoon and good morning to the US. My name is Anna Niedl. I'm responsible for the investor relations at Medigene. I would like to welcome everyone to today's conference call in which we will describe Medigene's financial and operational results in the first half year of 2022.
Today's presentation, as always, is available for download on our website. And this call will be recorded and will be accessible later on our website as well in the same section. With me today here on this conference call are Professor Dolores Schendel, our Chief Scientific Officer; and Dr. Birger Kohlert, our Chief Financial Officer.
I would now like to draw your attention to slide 2 of the presentation and would like to remind you, as usual, that during this conference call, we will present and discuss certain forward-looking statements. And with this said, I hand over to Dolores Schendel and slide 3 of the presentation.
Dolores Schendel - Medigene AG - Chief Scientific Officer
Thank you, Anna. So
Q2 2022 Medigene AG Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers